All articles by
What is an adaptive clinical trial?
Pharmaceutical and biotechnology companies are increasingly considering adaptive strategies in clinical trials, but what do they entail? Dr Les Huson, consultant biostatistician and honorary lecturer in medical statistics at the Division of Experimental Medicine, Imperial College London, has the answer.
Eastern Europe comes in from the cold
Although Eastern Europe offers challenges, it is increasingly being viewed as an attractive region to outsource clinical research to, as ClinStar’s David Passov tells Andrew Tunnicliffe.
How to recruit for better outcomes
Recruiting the right sample group is crucial to the outcome of a trial but the process can be burdensome and expensive. There is a debate about how to identify the right group of participants for a trial to maximise its potential, with pre-selection becoming a key element. Heather DiBenedetto of Novartis takes a look at how to improve the recruitment process.
Optimal planning for clinical supply
Supply of clinical trial material (CTM), on time, in full, in the right place and of the right quality can be critical to the initiation of clinical studies. Hedley Rees of PharmaFlow reveals the factors for success.
Drugs in wastewater changing fish behaviour
Fish behaviour is changing as a result of pharmaceutical product waste, according to a recent study. A team at Umeå University said that drugs excreted from the human body are finding their way into wastewater and making fish fearless, gluttonous and antisocial. Their work was published in Science journal.
New £169.5m project to facilitate drug discovery
Pharma, academia and small and medium-sized enterprises have announced a collaboration aimed at facilitating drug discovery. The European Lead Factory, backed by the Innovative Medicines Initiative (IMI), will collect and retain small molecules, comprising more than 300,000 substances, over the five-year term of the project.
US overdose deaths continue to rise
The number of US citizens dying from drug overdoses has risen for the 11th year in a row, according to the latest figures. However, according to the US Centers for Disease Control and Prevention (CDC), the drug-related deaths are mostly associated with addictive painkillers.
Thailand fails to protect pharmaceutical patents
Thai authorities are failing to protect pharmaceutical patents and creating an environment less attractive to investors. That is one of the conclusions of a new report published by global research and consulting firm GlobalData.
Take five: significant pharma industry deals in Q2/Q3
With insight from GlobalData, we take a look at five of the recent deals in the pharmaceutical world.
Top ten generic companies
GlobalData highlights the top ten generic pharmaceutical companies by revenue during the year ending 2011.